Glycaemic control and cardiovascular morbi-mortality: The contribution of the 2008 studies

Annales d'Endocrinologie

Volumn 70, Issue 1, 2009, Pages 48-54

  Cugnet Anceau, C ^a   Bauduceau, B ^b  

^a LOUIS PRADEL HOSPITAL   (France)

^b SERVICE D ENDOCRINOLOGIE   (France)

Author keywords

Diabetes; Glycaemic control; Macrovascular complications; Microvascular complications; Studies

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLICLAZIDE; GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; INDAPAMIDE; INSULIN; METFORMIN; PERINDOPRIL; SULFANILAMIDE;

AGE DISTRIBUTION; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE DURATION; DRUG EFFICACY; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INTENSIVE CARE; MICROANGIOPATHY; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; RISK FACTOR; SHORT SURVEY; UNITED KINGDOM;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; HOMEOSTASIS; HUMANS; HYPERGLYCEMIA;

EID: 61449084449     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2008.12.008     Document Type: Short Survey

References (18)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. Nathan D.M., Cleary P.A., Backlund J.Y., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 (2005) 2643-2653
3. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000;342:381-9.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
5. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352:854-65.
6. Stratton I.M., Adler A.I., Neil H.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
7. Gerstein H.C., Miller M.E., Byington R.P., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 (2008) 2545-2559
8. Nathan D.M., et al. Modern-day clinical course of type 1 diabetes mellitus: the DCCT/EDIC experience 1983-2008. Diabetologia 51 (2008) S50
9. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., and Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359 (2008) 1577-1589
10. Patel A., MacMahon S., Chalmers J., et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 370 (2007) 829-840
11. Patel A., MacMahon S., Chalmers J., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358 (2008) 2560-2572
12. Dluhy R.G., and McMahon G.T. Intensive glycaemic control in the ACCORD and ADVANCE trials. N Engl J Med 358 (2008) 2630-2633
13. Cefalu W.T. Glycaemic targets and cardiovascular disease. N Engl J Med 358 (2008) 2633-2635
14. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-13.
15. Holman R.R., Paul S.K., Bethel M.A., Neil H.A., and Matthews D.R. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 359 (2008) 1565-1576
16. Gaede P., Vedel P., Larsen N., Jensen G.V., Parving H.H., and Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348 (2003) 383-393
17. Gaede P., Lund-Andersen H., Parving H.H., and Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358 (2008) 580-591
18. Nathan D.M., Buse J.B., Davidson M.B., et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 31 (2008) 173-175